DaVita healthCare Partners Inc Stock News

Solid performance within net dialysis and related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in Q2.

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time. The company plans to r

The recent sale of DaVita stock by Berkshire Hathaway is not indicative of either Warren Buffett or Ted Weschler souring on the stock.

Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.

Top Ranked Growth Stocks to Buy for July 9th

DVA vs. CHE: Which Stock Is the Better Value Option?

Is (DVA) Outperforming Other Medical Stocks This Year?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market

HighTower Advisors LLC lessened its holdings in shares of Davita Inc (NYSE:DVA) by 81.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fi

Investor confidence is high on DaVita (DVA), thanks to solid prospects.

Here's the latest article in the Sun: https://bit.ly/2YPF18W...

FDA WARNING: These 9 hand sanitizers can be toxic; stop use...